Changes of NLF in Serum of Long COVID Patients
1 other identifier
observational
30
1 country
1
Brief Summary
The study investigates the blood NFL levels in Long-COVID patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2020
CompletedFirst Submitted
Initial submission to the registry
August 9, 2021
CompletedFirst Posted
Study publicly available on registry
September 29, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2021
CompletedApril 28, 2023
April 1, 2023
1.4 years
August 9, 2021
April 26, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Levels of NFL over a 1 year course of the Long-COVID Syndrom
see above
1 year
Study Arms (2)
LONGCOVID
Patient with Long-COVID Syndrom
CONTROLS
Healthy individials
Interventions
Eligibility Criteria
Patients with Long-COVID-Syndrome
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (1)
Laura de Boni
Bonn, 53105, Germany
Biospecimen
Serum
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
August 9, 2021
First Posted
September 29, 2021
Study Start
June 1, 2020
Primary Completion
October 31, 2021
Study Completion
November 1, 2021
Last Updated
April 28, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share